CEVA heads into the week's close with a sharp one-day selloff and an options market flashing the most defensive signal it has shown in months — a jarring contrast to a stock that had rallied 15% over the prior month.
The options story is the standout this week. The put/call ratio spiked to 0.23 on Tuesday, more than three standard deviations above its 20-day average of 0.15 — its largest z-score in recent memory and well above the run-rate the stock has maintained since early May. For a name that has been trading close to call-heavy for the better part of two months, the sudden demand for downside protection is notable. Short interest tells a calmer story: at 5.2% of free float and falling — down 27% over the past month alone — bears have been retreating, not building. Borrow conditions confirm the lack of conviction on the short side. Cost to borrow has eased to 0.43%, its lowest reading in six weeks, down 21% on the week. Availability is exceptionally loose at over 2,000% — meaning shares to lend dwarf the current short position by a wide margin — so the lending market poses no constraint on new positioning in either direction.
The Street arrived at this week looking broadly constructive on CEVA. Needham initiated coverage on June 15 with a Buy and a $55 target, the most bullish call on the board. JPMorgan, which initiated in early May at Neutral with a $30 target, nudged that to $36 following the Q1 print — still a notable discount to the consensus mean near $46. The broad picture is of a cohort that raised targets aggressively after the May earnings beat — UBS moved from $27 to $42, then $48; TD Cowen nearly doubled its target in a single step — while JPMorgan stays cautious on valuation. The bull thesis, as articulated by the coverage, rests on CEVA's positioning in Physical AI chip IP and the compounding royalty stream as edge devices proliferate. Bears point to execution risk around Physical AI adoption timelines and intensifying competition in semiconductor IP licensing. Valuation multiples already reflect optimism: the trailing P/E has expanded to roughly 75x, up more than 13 points over 30 days, and EV/EBITDA runs above 52x.
The institutional register adds a wrinkle. The 90-day insider net is technically positive in share terms, but the direction of recent trades runs the other way. Two independent directors and the COO all sold in May and early June at prices between $36 and $46 — small in aggregate but consistent in direction. The February cluster of buying by the CEO, CFO, and a director at around $19 looks more like a conviction call at depressed prices than a current signal. BlackRock and State Street both added materially through May, while Senvest — the largest holder at 8.5% — trimmed modestly at the March quarter-end. Overall, institutional ownership is orderly rather than skewed.
MRVL fell 9.4% on the day and ALGM dropped nearly 10%, suggesting Tuesday's selloff for CEVA was part of a wider semiconductor washout rather than a stock-specific event. SYNA also declined 6.5%, closely matching CEVA's move. That context matters: the question for the next few sessions is whether the put/call spike reflects temporary sector-wide hedging or the start of a more targeted repositioning ahead of the August 12 earnings date.
The next quarterly print on August 12 is where the narrative resolves — either validating the aggressive target upgrades from May or testing whether the Physical AI adoption curve is moving as quickly as the bull case assumes.
See the live data behind this article on ORTEX.
Open CEVA on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
